1. Niemegeers C.J.E., Lenaerts F.M. and Janssen P.A.J. (1974). Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 1: In vivo oral pharmacology and acute toxicity. Comparison with morphine, codeine, diphenoxylate and difenoxine, Arzneimittel-Forsch.,24, 1633–1636.
2. Niemegeers C.J.E., Lenaerts F.M. and Janssen P.A.J. (1974). Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 2: In vivo parenteral pharmacology and acute toxicity in mice. Comparison with morphine, codeine and diphenoxylate, Arzneimittel-Forsch.,24, 1636–1641.
3. Van Nueten J.M., Janssen P.A.J. and Fontaine J. (1974). Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 3: In vitro studies on the peristaltic reflex and other experiments on isolated tissues, Arzneimittel-Forsch.,24, 1641–1645.
4. Marsboom R., Herin V., Verstraeten A., Vandesteene R. and Fransen J. (1974). Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 4: Studies on subacute and chronic toxicity and on reproductive processes in rats, dogs and rabbits, Arzneimittel-Forsch.,24, 1645–1649.
5. Schuermans V., Van Lommel R., Dom J. and Brugmans J. (1974). Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 6: Clinical pharmacology. Placebocontrolled comparison of the constipating activity and safety of loperamide, diphenoxylate and codeine in normal volunteers, Arzneimittel-Forsch.,24, 1653–1657.